-
Je něco špatně v tomto záznamu ?
Brain age in bipolar disorders: Effects of lithium treatment
H. Van Gestel, K. Franke, J. Petite, C. Slaney, J. Garnham, C. Helmick, K. Johnson, R. Uher, M. Alda, T. Hajek,
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články
Grantová podpora
NV16-32791A
MZ0
CEP - Centrální evidence projektů
NV16-32791A
MZ0
CEP - Centrální evidence projektů
PubMed
31244332
DOI
10.1177/0004867419857814
Knihovny.cz E-zdroje
- MeSH
- bipolární porucha diagnostické zobrazování farmakoterapie MeSH
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- magnetická rezonanční tomografie MeSH
- mozek diagnostické zobrazování patologie MeSH
- multivariační analýza MeSH
- neuroprotektivní látky farmakologie MeSH
- sloučeniny lithia farmakologie MeSH
- strojové učení MeSH
- věkové faktory MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
OBJECTIVE: Bipolar disorders increase the risk of dementia and show biological and brain alterations, which resemble accelerated aging. Lithium may counter some of these processes and lower the risk of dementia. However, until now no study has specifically investigated the effects of Li on brain age. METHODS: We acquired structural magnetic resonance imaging scans from 84 participants with bipolar disorders (41 with and 43 without Li treatment) and 45 controls. We used a machine learning model trained on an independent sample of 504 controls to estimate the individual brain ages of study participants, and calculated BrainAGE by subtracting chronological from the estimated brain age. RESULTS: BrainAGE was significantly greater in non-Li relative to Li or control participants, F(2, 125) = 10.22, p < 0.001, with no differences between the Li treated and control groups. The estimated brain age was significantly higher than the chronological age in the non-Li (4.28 ± 6.33 years, matched t(42) = 4.43, p < 0.001), but not the Li-treated group (0.48 ± 7.60 years, not significant). Even Li-treated participants with partial prophylactic treatment response showed lower BrainAGE than the non-Li group, F(1, 64) = 4.80, p = 0.03. CONCLUSIONS: Bipolar disorders were associated with greater, whereas Li treatment with lower discrepancy between brain and chronological age. These findings support the neuroprotective effects of Li, which were sufficiently pronounced to affect a complex, multivariate measure of brain structure. The association between Li treatment and BrainAGE was independent of long-term thymoprophylactic response and thus may generalize beyond bipolar disorders, to neurodegenerative disorders.
Department of Psychiatry Dalhousie University Halifax NS Canada
Structural Brain Mapping Group Department of Psychiatry Jena University Hospital Jena Germany
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20025420
- 003
- CZ-PrNML
- 005
- 20201222153910.0
- 007
- ta
- 008
- 201125s2019 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1177/0004867419857814 $2 doi
- 035 __
- $a (PubMed)31244332
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Van Gestel, Holly $u Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
- 245 10
- $a Brain age in bipolar disorders: Effects of lithium treatment / $c H. Van Gestel, K. Franke, J. Petite, C. Slaney, J. Garnham, C. Helmick, K. Johnson, R. Uher, M. Alda, T. Hajek,
- 520 9_
- $a OBJECTIVE: Bipolar disorders increase the risk of dementia and show biological and brain alterations, which resemble accelerated aging. Lithium may counter some of these processes and lower the risk of dementia. However, until now no study has specifically investigated the effects of Li on brain age. METHODS: We acquired structural magnetic resonance imaging scans from 84 participants with bipolar disorders (41 with and 43 without Li treatment) and 45 controls. We used a machine learning model trained on an independent sample of 504 controls to estimate the individual brain ages of study participants, and calculated BrainAGE by subtracting chronological from the estimated brain age. RESULTS: BrainAGE was significantly greater in non-Li relative to Li or control participants, F(2, 125) = 10.22, p < 0.001, with no differences between the Li treated and control groups. The estimated brain age was significantly higher than the chronological age in the non-Li (4.28 ± 6.33 years, matched t(42) = 4.43, p < 0.001), but not the Li-treated group (0.48 ± 7.60 years, not significant). Even Li-treated participants with partial prophylactic treatment response showed lower BrainAGE than the non-Li group, F(1, 64) = 4.80, p = 0.03. CONCLUSIONS: Bipolar disorders were associated with greater, whereas Li treatment with lower discrepancy between brain and chronological age. These findings support the neuroprotective effects of Li, which were sufficiently pronounced to affect a complex, multivariate measure of brain structure. The association between Li treatment and BrainAGE was independent of long-term thymoprophylactic response and thus may generalize beyond bipolar disorders, to neurodegenerative disorders.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a věkové faktory $7 D000367
- 650 _2
- $a bipolární porucha $x diagnostické zobrazování $x farmakoterapie $7 D001714
- 650 _2
- $a mozek $x diagnostické zobrazování $x patologie $7 D001921
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a sloučeniny lithia $x farmakologie $7 D018020
- 650 _2
- $a strojové učení $7 D000069550
- 650 _2
- $a magnetická rezonanční tomografie $7 D008279
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a multivariační analýza $7 D015999
- 650 _2
- $a neuroprotektivní látky $x farmakologie $7 D018696
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Franke, Katja $u Structural Brain Mapping Group, Department of Psychiatry, Jena University Hospital, Jena, Germany.
- 700 1_
- $a Petite, Joanne $u Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
- 700 1_
- $a Slaney, Claire $u Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
- 700 1_
- $a Garnham, Julie $u Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
- 700 1_
- $a Helmick, Carl $u Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
- 700 1_
- $a Johnson, Kyle $u Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
- 700 1_
- $a Uher, Rudolf $u Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
- 700 1_
- $a Alda, Martin $u Department of Psychiatry, Dalhousie University, Halifax, NS, Canada. National Institute of Mental Health, Klecany, Czech Republic.
- 700 1_
- $a Hajek, Tomas $u Department of Psychiatry, Dalhousie University, Halifax, NS, Canada. National Institute of Mental Health, Klecany, Czech Republic.
- 773 0_
- $w MED00000625 $t The Australian and New Zealand journal of psychiatry $x 1440-1614 $g Roč. 53, č. 12 (2019), s. 1179-1188
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31244332 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20201222153906 $b ABA008
- 999 __
- $a ok $b bmc $g 1599565 $s 1116106
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 53 $c 12 $d 1179-1188 $e 20190627 $i 1440-1614 $m Australian and New Zealand journal of psychiatry $n Aust N Z J Psychiatry $x MED00000625
- GRA __
- $a NV16-32696A $a NV16-32791A $p MZ0 $p MZ0
- GRA __
- $a NV16-32696A $a NV16-32791A $p MZ0 $p MZ0
- LZP __
- $a Pubmed-20201125